Ignite Creation Date:
2024-05-06 @ 6:20 PM
Last Modification Date:
2024-10-26 @ 2:46 PM
Study NCT ID:
NCT05627245
Status:
RECRUITING
Last Update Posted:
2024-07-03
First Post:
2022-11-23
Brief Title:
Testing the Safety of the Anti-cancer Drugs Tazemetostat and Belinostat in Patients With Lymphomas That Have Resisted Treatment
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-03-01
Start Date Type:
ACTUAL
Primary Completion Date:
2025-03-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-03-01
Completion Date Type:
ESTIMATED
First Submit Date:
2022-11-23
First Submit QC Date:
November 23 2022
Study First Post Date:
2022-11-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-23
Last Update Post Date:
2024-07-03
Last Update Post Date Type:
ACTUAL